1. Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor
   Nupur K. Purohit et al, 2018, Oncotarget CrossRef
2. The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts
   Sara Lundsten et al, 2020, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
3. The PI3K/Akt Pathway in Tumors of Endocrine Tissues
   Helen Louise Robbins et al, 2016, Frontiers in Endocrinology CrossRef
4. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
   Sylvia L. Asa et al, 2021, Endocrine Pathology CrossRef